| QUALIGEN THERAPEUTICS |
| USA |
| Gesundheit |
| US74754R3012 / A40THA |
| 7R90 (Frankfurt) / QLGN (NASDAQ) |
| FRA:7R90, ETR:7R90, 7R90:GR, NASDAQ:QLGN |
| - |
| https://qlgntx.com/ |
| - |
| 12.89 Mio. EUR |
| 13.38 Mio. EUR |
| - |
| -6.22 Mio. EUR |
| -6.27 Mio. EUR |
| -7.51 EUR |
| 2.81 Mio. EUR |
| 33.64 Mio. EUR |
| -6.16 Mio. EUR |
| 7.88 |
| - |
| 7.02% |
| - |
| - |
| - |
| - |
| QUALIGEN |
| 16.12.25 |
|